ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

Tapan Kadia, MD, Highlights Venetoclax Plus Chemotherapy for AML, MDS

Oncology Learning Network

11/11/2021 6 min

Tapan Kadia, MD, Highlights Venetoclax Plus Chemotherapy for AML, MDS

Listen "Tapan Kadia, MD, Highlights Venetoclax Plus Chemotherapy for AML, MDS"

Descargar episodio

Episode Synopsis

Tapan M. Kadia, MD, highlights a phase 2 trial on venetoclax plus intensive chemotherapy in patients with newly diagnosed AML or MDS.

More episodes of the podcast Oncology Learning Network

Navigating The Complexity of Melanoma Care: Part 6 21/05/2025

Navigating The Complexity of Melanoma Care: Part 5 21/05/2025

Navigating The Complexity of Melanoma Care: Part 4 21/05/2025

Navigating The Complexity of Melanoma Care: Part 3 21/05/2025

Navigating The Complexity of Melanoma Care: Part 2 21/05/2025

Navigating The Complexity of Melanoma Care: Part 1 21/05/2025

Community Education Program Improves Patient Education and Cancer Screening Rates 14/05/2025

Cholangioscopy: What Interventional Oncologists Need to Know Part 2 21/08/2024

Cholangioscopy: What Interventional Oncologists Need to Know 21/08/2024

Applications of AR in Interventional Oncology 20/06/2024

Ver todos los episodios